Veracyte
VCYT
298 hedge funds and large institutions have $3.08B invested in Veracyte in 2025 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 95 increasing their positions, 90 reducing their positions, and 46 closing their positions.
955% more call options, than puts
Call options by funds: $3.29M | Put options by funds: $312K
52% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 46
33% more capital invested
Capital invested by funds: $2.31B → $3.08B (+$772M)
7% more funds holding
Funds holding: 278 → 298 (+20)
5.02% more ownership
Funds ownership: 109.03% → 114.05% (+5%)
6% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 90
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$153M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$33.5M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$30.1M |
| 4 |
State Street
Boston,
Massachusetts
|
+$29.5M |
| 5 |
FAM
Fred Alger Management
New York
|
+$22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.6M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$27.9M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$23M |
| 4 |
Squarepoint
New York
|
-$21M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16.7M |
VCYT Hedge Fund Activity: Q3 2025 in Review
298 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2025, worth a combined $3.08B — up 33% from $2.31B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new VCYT positions and 46 closed out — a net gain of 24 holders — while 95 added to existing stakes and 90 trimmed.
The largest buyer was BlackRock, adding an estimated $153M. The largest seller was Fidelity Investments, cutting an estimated $37.6M.
- 298 institutional investors held Veracyte (VCYT) as of Q3 2025, up from 278 in Q2 2025.
- Funds reported $3.08B of Veracyte stock for Q3 2025, up 33% quarter-over-quarter.
- 70 funds opened new Veracyte positions in Q3 2025 and 46 closed out, a net change of +24 holders.
- The largest Veracyte buyer in Q3 2025 was BlackRock, an estimated $153M added.
- The largest Veracyte seller in Q3 2025 was Fidelity Investments, an estimated $37.6M sold.
Based on aggregated 13F filings for Q3 2025.